The UK Government has announced a £40m grant to drive brain cancer research under the Tessa Jowell Brain Cancer Research Mission.
Tessa Jowell, a British politician, died on 12 May this year after suffering from brain cancer.
11,400 people in the UK are affected by brain tumours each year. Of the total patients, only 14% survive for ten years or more.
The research programme is in line with Jowell’s goal to enhance care and outcomes for patients suffering from the disease.
Health Minister Lord James O’Shaughnessy said: “We are deeply saddened by this loss. Tessa Jowell did more than anyone to shine a light on the need to improve research and care for people with brain cancer.
“It is a great privilege and honour to take forward this work, which we hope will boost life-saving research and transform brain cancer care in the way that Tessa called for.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe project will initially involve an investment of £65m, of which £25m will be contributed by Cancer Research UK, with plans to increase the funding each year based on research proposals.
The research fund will be used to support new clinical commitments such as the launch of a dye developed to identify tumours during brain cancer surgery. At present, the dye is only available in 50% of England’s brain cancer centres.
The commitments also include the advancement of adaptive trials designed to simultaneously assess multiple treatments to speed up the process.
The UK Government will host a new Tessa Jowell global symposium, which will bring together the clinical, scientific and academic experts on brain cancer to identify gaps, best practice and priorities in research.